<DOC>
	<DOCNO>NCT01106989</DOCNO>
	<brief_summary>The purpose pilot study explore potential usefulness heat lidocaine 70 mg tetracaine 70 mg topical patch treatment pain associate myofascial trigger point .</brief_summary>
	<brief_title>Study Evaluating Heated Lidocaine/Tetracaine Patch Patients With Pain Associated With Myofascial Trigger Points</brief_title>
	<detailed_description>The purpose pilot study explore usefulness heat lidocaine 70 mg tetracaine 70 mg topical patch treatment pain associate myofascial trigger point . The study consist 2-week , open-label treatment period follow 2 week follow-up period conduct single study site . Eligible patient must clinical diagnosis pain ( minimum 1-month duration ) associate 3 identifiable myofascial trigger point . A number efficacy variable employ evaluate utility assess painful response population .</detailed_description>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>least 18 year age clinical diagnosis pain ( minimum 1month duration ) associate 3 myofascial trigger point trigger point confine upper back , shoulder , neck use topically applied pain medication target treatment area within 3 day precede Screening/Baseline Visit use topically apply pain medication target treatment area within 3 day precede Screening/Baseline Visit use injected pain medication 28 day precede Screening/Baseline Visit receive class 1 antiarrhythmic drug ( ie , tocainide , mexiletine , etc . ) Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>